To identify the most appropriate concentration of COX-2 inhibitor to use in the next experiments, GBM cells were treated with increasing concentrations of NS398 (50–400 μM) to continuously evaluate the cell growth by IncuCyte® Live Cell Imager instrument every 4 h for a total timeline of 3 days (72 h). Here, PTGS2 is linked to glioblastoma.